Institutional Council Chair:


2023-2024 Chair:

Peter Wirth 

Vice President, Business Development, RTI Health Solutions

Durham, NC, USA


Institutional Council Chair Elect:


2024-2025 Chair:

Julian Shepelev

Associate Director, EMEA Government Affairs, Market Access, HEOR and Reimbursement, Baxter Pharmaceuticals

London, England, UK


Institutional Council Past Chairs:


2022-2023 Chair:

Hemant Phatak  
Head, Global Health Economics and Outcomes Research, Amylyx Pharmaceuticals 
Cambridge, MA, USA

2021-2022 Chair:

Ami Buikema 

Principal Consultant, Vice President, HEOR, Optum 
Eden Prairie, MN, USA


2020-2021 Chair:

William Marder

Bill Marder

Chief Data Strategist, IBM Watson Health
Cambridge, MA, USA


2019 Chair:

VanBrunt_David

David Van Brunt

Senior Director, Global HEOR, AbbVie
Chicago, IL, USA


2018 Chair:

Pamela_Blumberg

Pamela Blumberg, MPH, DrPH

Lead, Real-world Evidence Strategy, TriNetX
Fort Mill, SC, USA


2017 Chair:

Chiraky-Mark

Mark Cziraky, PharmD

Vice President, Research, HealthCore, Inc.
Wilmington, DE, USA


2016 Chair:

Murray-James

James Murray, PhD

Research Fellow, Global Health Outcomes and COE, Eli Lilly and Co.
Carmel, IN, USA


2015 Chair:

SheldonKong

Sheldon Kong, PhD

Executive Director, Health Economics and Outcomes Research
Novo Nordisk Inc.
Plainsboro, NJ, USA

2014 Chair:

Yin_Donald

Donald Yin, PhD

Vice President
Merck
Upper Gwynedd, PA, USA

2013 Chair:

ODonnell-John

John O'Donnell, PhD

Vice President, Global Health Outcomes
Bristol-Myers Squibb Co.
Princeton, NJ, USA

2012 Past Chair:


Phillip Sarocco, RPh, MSc

Head, Health Economics & Outcomes Research,
IRONWOOD Pharmaceuticals
Cambridge, MA, USA

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×